JP2006516273A5 - - Google Patents

Download PDF

Info

Publication number
JP2006516273A5
JP2006516273A5 JP2006500200A JP2006500200A JP2006516273A5 JP 2006516273 A5 JP2006516273 A5 JP 2006516273A5 JP 2006500200 A JP2006500200 A JP 2006500200A JP 2006500200 A JP2006500200 A JP 2006500200A JP 2006516273 A5 JP2006516273 A5 JP 2006516273A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally
further optionally
cycloalkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006500200A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006516273A (ja
JP4688785B2 (ja
Filing date
Publication date
Priority claimed from SE0300092A external-priority patent/SE0300092D0/xx
Application filed filed Critical
Publication of JP2006516273A publication Critical patent/JP2006516273A/ja
Publication of JP2006516273A5 publication Critical patent/JP2006516273A5/ja
Application granted granted Critical
Publication of JP4688785B2 publication Critical patent/JP4688785B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006500200A 2003-01-15 2004-01-13 チオフェン−カルボキサミド誘導体および酵素ikk−2インヒビターとしてのその使用 Expired - Fee Related JP4688785B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0300092A SE0300092D0 (sv) 2003-01-15 2003-01-15 Novel compounds
SE0300092-4 2003-01-15
PCT/GB2004/000096 WO2004063186A1 (en) 2003-01-15 2004-01-13 Thiophene-carboxamide derivatives and their use as inhibitors of the enzime ikk-2

Publications (3)

Publication Number Publication Date
JP2006516273A JP2006516273A (ja) 2006-06-29
JP2006516273A5 true JP2006516273A5 (enExample) 2007-02-22
JP4688785B2 JP4688785B2 (ja) 2011-05-25

Family

ID=20290127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006500200A Expired - Fee Related JP4688785B2 (ja) 2003-01-15 2004-01-13 チオフェン−カルボキサミド誘導体および酵素ikk−2インヒビターとしてのその使用

Country Status (5)

Country Link
US (2) US7572826B2 (enExample)
EP (1) EP1583755A1 (enExample)
JP (1) JP4688785B2 (enExample)
SE (1) SE0300092D0 (enExample)
WO (1) WO2004063186A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102616D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0300092D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300091D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
AU2004312193B2 (en) * 2004-01-05 2008-09-25 Astrazeneca Ab Thiophene derivatives as CHK 1 inihibitors
WO2005105777A1 (en) * 2004-05-05 2005-11-10 Pharmacia & Upjohn Company Llc Substituted thiophene amide compounds for the treatment of inflammation
US20060188445A1 (en) * 2005-02-22 2006-08-24 Fred Hutchinson Cancer Research Center Assay for compounds that protect against sensory hair cell death and compounds identified by same
US8106091B2 (en) 2006-11-01 2012-01-31 Chroma Therapeutics Ltd. Inhibitors of IKK-beta serine-threonine protein kinase
BRPI0718056A2 (pt) * 2006-11-01 2013-11-05 Chroma Therapeutics Ltd Inibidores da proteína cinase ikk-beta serina-treonina
WO2008087933A1 (ja) * 2007-01-15 2008-07-24 Santen Pharmaceutical Co., Ltd. IκBキナーゼβ阻害活性を有する新規インドール誘導体
AU2008266883B2 (en) * 2007-06-20 2014-01-30 Merck Sharp & Dohme Corp. Inhibitors of janus kinases
JPWO2009096198A1 (ja) * 2008-02-01 2011-05-26 一般社団法人ファルマIp 新規ビアリール誘導体
BRPI0911480A2 (pt) * 2008-04-26 2018-04-03 Chroma Therapeutics Ltd inibidores de proteínas serina-treonina quinase ikk-beta
US8445529B2 (en) * 2008-07-14 2013-05-21 Santen Pharmaceutical Co., Ltd. Indole derivative having, carbamoyl group, ureido group and substituted oxy group
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
US20110135756A1 (en) * 2009-12-08 2011-06-09 University Of Washington Compositions and methods for protecting sensory hair cells
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
GB201021979D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab New compound

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1098240A (en) * 1903-01-23 1914-05-26 United Shoe Machinery Ab Skiving-machine.
US1084171A (en) * 1910-09-13 1914-01-13 New York Attachable Player Action Co Player-piano.
GB1468012A (en) 1973-08-09 1977-03-23 Beecham Group Ltd 2-amino-3-carboxy-thiophene derivatives
DE3529247A1 (de) 1985-05-17 1986-11-20 Bayer Ag, 5090 Leverkusen Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
GB2195634B (en) 1986-10-01 1990-08-15 Roussel Lab Ltd Thiophene derivatives
US5258357A (en) * 1989-10-07 1993-11-02 Basf Aktiengesellschaft Carboxamides, their preparation and their use as herbicides
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
US5571810A (en) * 1990-06-11 1996-11-05 Fujisawa Pharmaceutical Co., Ltd. Thiophene derivatives
US5514801A (en) * 1992-12-29 1996-05-07 Monsanto Company Cyclic sulfone containing retroviral protease inhibitors
WO1998002430A1 (en) 1996-07-11 1998-01-22 Pfizer Pharmaceuticals Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
PT853083E (pt) 1997-01-06 2001-12-28 Pfizer Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
US6809088B2 (en) * 1997-03-24 2004-10-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
US6037340A (en) 1997-05-28 2000-03-14 Cadus Pharmaceutical Corporation Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
DE19744026A1 (de) 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
WO1999046244A1 (en) 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
BR9911914B1 (pt) * 1998-07-08 2010-10-19 n-arilamidas do ácido sulfonilaminocarboxìlico substituìdas por enxofre, processo para sua preparação, bem como preparações farmacêuticas que compreendem as mesmas.
DE60009260T2 (de) * 1999-01-07 2004-08-05 Fujisawa Pharmaceutical Co., Ltd. Thiopyranderivate as mmp-inhibitoren
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
GB0003154D0 (en) 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
IL151946A0 (en) * 2000-03-29 2003-04-10 Cyclacel Ltd 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
US6414013B1 (en) 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
DE10034624A1 (de) * 2000-07-17 2002-01-31 Bayer Ag Aryl-substituierte Thienyl-1,3-oxazolidin-2-one als Cytokin-Inhibitoren
WO2002030353A2 (en) 2000-10-12 2002-04-18 Smithkline Beecham Corporation NF-λB INHIBITORS
US7122544B2 (en) 2000-12-06 2006-10-17 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
US6713638B2 (en) * 2001-05-18 2004-03-30 Joel M. Linden 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
PT1401825E (pt) * 2001-06-11 2009-10-23 Virochem Pharma Inc Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0102617D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
WO2003029241A1 (en) 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
WO2003028731A1 (en) 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
WO2003029242A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation NF-λB INHIBITORS
TWI281916B (en) * 2001-10-25 2007-06-01 Lilly Co Eli Antitumor compounds and methods
US6835745B2 (en) * 2002-01-15 2004-12-28 Wyeth Phenyl substituted thiophenes as estrogenic agents
US7196106B2 (en) * 2002-11-05 2007-03-27 Merck & Co., Inc Cyanothiophene derivatives, compositions containing such compounds and methods of use
SE0300092D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300091D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
CA2534535A1 (en) * 2003-08-27 2005-03-10 Ciba Specialty Chemicals Holding Inc. Composition and process for the controlled synthesis of block copolymers
AU2004312193B2 (en) * 2004-01-05 2008-09-25 Astrazeneca Ab Thiophene derivatives as CHK 1 inihibitors

Similar Documents

Publication Publication Date Title
JP2006516273A5 (enExample)
JP2010528089A5 (enExample)
AR063946A1 (es) Determinadas pirimidinas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden.
EA200602290A1 (ru) Лиганды crth2 рецептора и их применение
HRP20140201T1 (hr) Kondenzirani cikliäśki spojevi kao modulatori gpr40-receptora
JP2013509392A5 (enExample)
AR040351A1 (es) Derivados de quinuclidina-amida, composicion farmaceutica, procedimiento de preparacion del compuesto y su uso para fabricar medicamentos
RS65642B1 (sr) Supstituisani pirazolo(1,5-a)pirimidini i njihova upotreba u lečenju medicinskih poremećaja
JPS58185553A (ja) α−保護されたオキシイミノ−β−ケト−γ−ハロゲノ酪酸類
HRP20170638T1 (hr) MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI
AR043679A1 (es) Derivados de acetil 2-hidroxi-1,3-diaminoalcanos, metodos de preparacion de los mismos y su uso en la fabricacion de medicamentos para el tratamiento o prevencion del mal de alzheimer
HRP20140723T1 (hr) Postupak za proizvodnju rosuvastatina
CA2716961A1 (fr) Composes derives d'azetidines, leur preparation et leur application en therapeutique
HRP20151439T1 (hr) Halogenirani derivati benzamida
CN104262309B (zh) 一种色酮类衍生物及其合成方法
WO2001062708A1 (fr) Derives d'acide benzoique, procede de production desdits derives, et medicament contenant ces derives comme principe actif
ES2602962T3 (es) Derivado de fenilazol sustituido
AU2015247575C1 (en) Polycyclic hERG activators
Pessoa‐Mahana et al. Synthesis of 4‐arylpiperazine derivatives of moclobemide: Potential antidepressants with a dual mode of action
CN104610037A (zh) β-三氟甲基-β-羟基酮的制备方法
Dos Santos et al. Improved Ritter reaction with CF3-containing oxirane for an access to central units of protease inhibitors
Tian et al. C sp 3–H Bond Functionalization of α-Bromo Ketones for the Synthesis of α-Keto Thioamides Using Elemental Sulfur
HRP20161485T1 (hr) Polimorfna forma n-[4-(trifluorometil)benzil)-4-metoksibutiramida
AR044828A1 (es) Derivados de 3-[4-(2-{4-[(metilsulfonil)oxi]fenoxi}etil)-fenil]propanoico
JPH04173782A (ja) 2―スルホンアミド―4,5―ジフェニルチアゾール誘導体